ROKIT brings innovative 3D bioprinting strategy for skin regeneration

ROKIT Healthcare, Inc., a regenerative medicine company focused on the development of novel regenerative therapeutic str...

February 20, 2019 | Wednesday | News
SK Biopharma to take antiepileptic drug to Europe

SK Biopharmaceuticals and Arvelle Therapeutics GmbH have announced that they have entered into an exclusive licensing ag...

February 18, 2019 | Monday | News
Bridge Bio presents Preclinical, Ph I study results for BBT-401

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, announced that the...

February 12, 2019 | Tuesday | News
OliX announces clinical candidate for Geographic Atrophy treatment

OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced the nomination of OLX10020 as a clin...

January 29, 2019 | Tuesday | News
US FDA approves Samsung Bioepis' first oncology drug

Samsung Bioepis has announced that the U.S. Food and Drug Administration has approved ONTRUZANT, a biosimilar referencin...

January 21, 2019 | Monday | News
Bridge Bio receives FDA ODD for IPF drug

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea and a tenant compan...

January 17, 2019 | Thursday | News
Glenmark enters commercialization agreement with Yuhan Corp

Glenmark Pharmaceuticals Ltd., a research-led global integrated pharmaceutical company, has announced that its Suisse su...

January 10, 2019 | Thursday | News
Norgine, Korea Pharma ink deal to commercialise PLENVU in Korea

NORGINE B.V. (Norgine), a leading European specialty pharmaceutical company and KOREA PHARMA CO., LTD. (Korea Pharma), a...

January 8, 2019 | Tuesday | News
Gilead Sciences, Yuhan to treat advanced fibrosis due to NASH

Gilead Sciences, Inc. and Yuhan Corporation has announced that the companies have entered into a licensing and collabora...

January 7, 2019 | Monday | News
South Korea IVD Market 2017-2022; overview by ResearchAndMarkets

South Korea is the 27th largest country worldwide with 51.2 million people as of 2017. In their healthcare market, ...

January 2, 2019 | Wednesday | News
Bridge Bio announces activation of clinical trial sites for Phase 2 study of UC drug candidate

Bridge Biotherapeutics Inc, a clinical stage biotech company headquartered in Seongnam, South Korea has announced that t...

December 28, 2018 | Friday | News
Eventi Telematici, Penta Security strengthens partnership for DataBreast

In recent years, several regulatory laws enforcing data privacy – that requires organizations to strengthen data p...

December 20, 2018 | Thursday | News
Bridge Bio signs $40M license agreement with Daewoong Pharma

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, has signed a licen...

December 19, 2018 | Wednesday | News
Celltrion, Teva announce FDA approval of HERZUMA

Celltrion, Inc. and Teva Pharmaceutical Industries Ltd. have announced that the U.S. Food and Drug Administration (FDA) ...

December 18, 2018 | Tuesday | News
Prestige, Cipla unite to sell cancer biosimilar HD201

Prestige BioPharma (“Prestige”) has reached a licensing agreement with Cipla Limited (“Cipla&rdqu...

December 14, 2018 | Friday | News
Avacta, LG Chem Life Sciences to develop novel drugs for cancer, inflammation

UK-based Avacta Group plc , the developer of Affimer biotherapeutics and reagents and Korea's LG Chem Life Science...

December 13, 2018 | Thursday | News
Ewha Medical Centre collaborates with GE Healthcare

Korea based Ewha Womans University Medical Centre has signed a Memorandum of Understanding (MoU) with GE Healthcare to c...

December 10, 2018 | Monday | News
Alteogen, Lynkogen expand agreement targeting NASH

South Korea based Alteogen Inc. and US based Lynkogen Inc. have announced that they have expanded the scope of their exc...

December 4, 2018 | Tuesday | News